
Net Migration Halves in a Year, But Still Far Higher Than Pre-Pandemic: ONS
Net migration nearly halved in the course of one year, but still remains far higher than in the previous years before the COVID-19 pandemic, according to figures from the Office for National Statistics (ONS).
In the year to December 2024, the difference between the number of people moving to the UK and leaving was an estimated 431,000, down 49.9 percent from 860,000 the year before, the largest numerical drop in any 12-month period.
The ONS's director of population statistics, Mary Gregory, said on Thursday that the decline was largely driven by a falling number of immigrants coming to the UK to work and study, 'particularly student dependants.'
This followed policy change from early 2024 by the previous Conservative government, which put in place
Long-Term Immigration Falls
The ONS said that the largest drop in immigration was from non-EU nationals coming here to work, falling 108,000, or 49 percent. Immigration for study purposes declined by 17 percent.
Long-term immigration also fell to 948,000, down 28.5 percent from 1,326,000 in the previous year, the first time in three years the figure was below 1 million.
Emigration also rose by around 11 percent to an estimated 517,000, up from 466,000 on the previous year. Gregory said that was especially owing to 'people leaving who originally came on study visas once pandemic travel restrictions to the UK were eased.'
Related Stories
5/12/2025
5/14/2025
The impact of Conservative policy on dependant visas saw an 86 percent (105,000) reduction in study dependants, and a 35 percent (81,000) decrease in the number of work dependants.
Home Secretary Yvette Cooper said that the fall in net migration is 'welcome after the figures quadrupled to nearly a million in the last parliament.'
'Our Immigration White Paper sets out radical reforms to further reduce net migration,' she added.
Shadow home secretary Chris Philp
He added that the figures were 'still far too high and need to go down a lot further.'
Higher Than Pre-Pandemic Levels
While these figures are a dramatic decline on 2022 and 2023, they are still far higher than the pre-pandemic era, and well above the pre-Brexit peak of roughly 300,000.
Net migration was broadly flat in the years leading up to the lockdown, standing at 208,000 in 2017, 276,000 in 2018, and 184,000 in 2019.
They then fell sharply in 2020 to 93,000, when travel restrictions were put in place.
Net migration then rose to 484,000 in 2021, 873,000 in 2022, and dropped slightly to 860,000 in 2023.
Estimated net migration to the UK.
PA Media
The Migration Observatory at the University of Oxford noted that this 'recording-breaking decline' was possible 'primarily because numbers had previously been so high.'
'The declines reflect a period of policy liberalisation post-Brexit which saw net migration reach a record 906,000 in the year to June 2023, followed by restrictions in early 2024, both under the previous government,' the Migration Observatory said.
For scale of how large a number current net migration figures still are, political commentator Matt Goodwin
Migration Observatory researcher Ben Brindle said that net migration figures will continue to fall, as the previous government's restrictions 'are not yet fully visible in the data.'
'Last week's policy proposals should reduce migration further, though by a small amount. Because these declines will not necessarily take us to particularly low levels, by historical standards,' he added.
'Relatively Small' Economic Impact
The Labour government has maintained the previous administration's visa rules, with Prime Minister Sir Keir Starmer announcing further measures to bring down legal immigration in the White Paper
These include ending the recruitment of overseas care workers, raising the skills requirements for visas to degree level, and charging universities a levy on international students.
Migration Observatory Director Madeleine Sumption said the economic impact of this fall in migrant workers is 'actually likely to be relatively small.'
She added, 'That's because the groups that have driven the decline, such as study and work dependants, are neither the highest skilled, highest-paid migrants who make substantial contributions to tax revenues, nor the most disadvantaged groups that require substantial support.'
Similarly, Downing Street indicated that it was not concerned that a fall in migrant workers would lead to a workforce shortage.
The prime minister's official spokesman said, 'We are, for the first time, setting out a strategy to properly bring together a domestic skills strategy together with an immigration strategy.'
'So we will be reducing our reliance on overseas labour by training up our domestic workforce and ensuring, as the public rightly expects, that our border system is secure,' he added.
PA Media contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
7 minutes ago
- Newsweek
Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Marjorie Taylor Greene has spoken out against a new COVID-19 vaccine being approved in the United States, saying the move is "not MAHA at all." Why It Matters Health Secretary Robert F. Kennedy Jr. is facing repeated backlash for some of his positions on health and medicine, including from people who would ordinarily support him. In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy Jr.'s pick for U.S. Surgeon General Casey Means. In March, Kennedy Jr. sparked anger from anti-vax activists when he called on parents to "consult with their healthcare providers to understand their options to get the MMR vaccine," with one saying he is "no different than Fauci." Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. AP What To Know The U.S. Food and Drug Administration (FDA) gave the green light for mNEXSPIKE (mRNA-1283), Moderna's new lower-dose COVID-19 vaccine, on May 31. Greene, the U.S. representative for Georgia's 14th congressional district, shared Moderna's post about the recent approval with the caption: "Not MAHA at all!!! Unreal." Not MAHA at all!!! Unreal. — Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) June 1, 2025 She was referring to Kennedy Jr.'s movement Make America Healthy Again, whose mission is to "aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases." Newsweek has contacted the United States Department of Health and Human Services outside of office hours, via email, for comment. The new vaccine is set to be used for adults 65 or older or people between the ages of 12 and 64 with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). Approval for the jab is "based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial which enrolled approximately 11,400 participants aged 12 years and older," Moderna says. It comes after Kennedy Jr. announced that the CDC is no longer encouraging COVID-19 vaccines for pregnant women and healthy children, marking a shift in federal public health guidance. What People Are Saying Chief Executive Officer of Moderna Stéphane Bancel said in a statement: "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." Kennedy Jr. said about the new CDC guidance: "I couldn't be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule." What Happens Next The new vaccine is expected to be ready for those eligible to take it in time for the 2025-2026 respiratory virus season. You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (an mRNA vaccine for preventing COVID-19) or any Moderna COVID-19 vaccine or to any ingredient in these vaccines, the company warns.

Yahoo
11 minutes ago
- Yahoo
Analysts assess the potential impact of Trump's surprise 50% steel tariffs
-- U.S. President Donald Trump unexpectedly announced on Friday that steel and aluminum tariffs will double to 50%. The move, set to come into effect on June 4, was unveiled during a campaign rally in Pennsylvania. It was later confirmed on TruthSocial and comes amid broader debates around U.S. industrial policy and foreign investment. Analysts are now evaluating the implications of this surprise decision, with most agreeing that the immediate domestic effects may be less severe than the broader geopolitical risks. JPMorgan's Tatsuya Maruyama said the direct impact on major Japanese steelmakers such as Nippon Steel Corp (TYO:5401), JFE Holdings, Inc. (TYO:5411), and Kobe Steel, Ltd. (TYO:5406) is expected to be limited, given that 'the U.S. accounts for about 4% of Japan's steel exports.' Maruyama pointed out in a Monday note that Nippon Steel and JFE export only about 1% of their total shipments to the U.S., while Kobe Steel exports about 3%. Still, he warned that 'rising global protectionism' is a growing concern, noting that a wave of anti-dumping measures and safeguards in regions like South Korea, the EU, and India could further strain global trade dynamics. 'If such countermeasures gain momentum, Japanese steel products may also be targeted and the export environment may worsen,' Maruyama continued. Meanwhile, analysts at BMO Capital Markets believe the sudden tariff hike could jolt domestic markets. 'The doubling of import tariffs, if maintained, is likely to create a panic in the market and trigger a restocking cycle that in our view has the potential to push prices >$1,000/st in the near-term,' the analysts said. However, they believe the spike would be temporary given macro uncertainty and seasonal demand trends. The broker upgraded Nucor (NYSE:NUE) to Outperform but downgraded Algoma Central (TSX:ALC), which it called 'a relative tariff loser.' The aluminum market may be more exposed, according to BMO. The U.S. covers only about 20% of its own aluminum consumption domestically, making it more vulnerable to supply disruptions. 'If tariffs do double, this is expected to put material upside pressure on the Midwest premium (MWP),' BMO wrote, estimating it could reach '$0.75/lb-plus' in theory, although higher aluminum cost will likely weigh on demand and thus offset some upside pressure. That said, the brokerage sees Century Aluminum (NASDAQ:CENX) as well positioned to benefit from a rise in the Midwest premium, while Alcoa (NYSE:AA) could see a negative impact of $1–2 per share, or 4–7%, due to its reliance on Canadian production. Still, BMO expects Alcoa may redirect some of its Canadian output to the EU market. Related articles Analysts assess the potential impact of Trump's surprise 50% steel tariffs Street Calls of the Week VIDEO: How to analyze a stock like a pro with the CEO of HF Foods
Yahoo
13 minutes ago
- Yahoo
European industry hit hard by Trump tariffs, Salzgitter CEO warns
DUESSELDORF/FRANKFURT (Reuters) -Salzgitter, Germany's second-biggest steelmaker, on Monday warned that Washington's tariff policy was dealing a severe blow to European industry, after the U.S. administration unveiled plans to double steel import levies to 50%. "The erratic tariff policy of the USA is hitting Europe's economy hard - especially Germany," Salzgitter CEO Gunnar Groebler said in a written statement. Shares in Salzgitter fell along with larger European peers Thyssenkrupp and ArcelorMittal, all down between 0.5 and 2.1%. Groebler said that apart from the direct tariffs on exports to the United States, there was also increased import pressure on the EU market as a result of rising volumes of cheaper Asian steel in Europe. According to Germany's steel association, the United States accounted for around a fifth, or 4 million tonnes, of European steel exports outside of the EU, making it the most important export market. "An increase in steel import duties in the USA to 50% should prompt the EU Commission to accelerate its efforts to implement the measures under the Steel and Metals Action Plan," Groebler said.